samwiise considering you frequent the daytrading thread, please stop the ramping BS.It appears someone (guessing Focus Asset) still has stock at 4.5 to offload
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%